AMERICAN JOURNAL OF GASTROENTEROLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1054059, encodeId=be481054059b8, content=请问一下，这个杂志投稿后需要每个作者确认吗？我投稿三天了还显示Submitted to Journal 是不是没有确认的原因啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Sep 23 09:21:08 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891913, encodeId=910a8919137f, content=三周以内投稿两篇letter，居然都接收了。letter的审稿还是比较快的，提交到系统后直接进入under review，中间时间变过几次，后面差不多一周时间就直接接到accept的通知了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Wed Oct 14 02:10:06 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926572, encodeId=b9fc9265e26a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3天秒拒，无理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb982473146, createdName=124403eem74暂无昵称, createdTime=Tue Feb 23 12:45:59 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908527, encodeId=027b90852e82, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿很快，没有实质yiji, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Wed Dec 16 13:05:08 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591503, encodeId=de6b59150325, content=请问with editor几天送审了后来？xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, beContent=xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587798, encodeId=7dca58e798b9, content=给各种战友友情提醒一下： 这个期刊不收动物模型的文章，谨慎选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:12:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583277, encodeId=017f5832e798, content=投稿后with editor第7天了，不知道有没有机会送外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a7e45998, createdName=xmcx783, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565021, encodeId=8a2b565021a4, content=IBD临床研究一篇，2018年5月8日投稿，7月18日一审结果建议大修，9月13日修回，10月23日二审结果建议1个月小修，10月24日修回，11月8日接收。12月30日Proof。等待在线中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aca20850, createdName=zhu19820122, createdTime=Mon Dec 31 23:18:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563647, encodeId=d29256364e61, content=请问一下，这个杂志接收基础文章吗？最近做了一个分子在肠炎中的作用，临床，细胞，动物都有。并纯化了该分子蛋白证明其有临床治疗价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Nov 26 00:00:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562218, encodeId=83da5622186e, content=投了个图片报道，审稿一个月了，今天变成了 Awaiting Final Decision。。。。就一个审稿人，战友们给评估下，希望多大？担忧中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Sun Oct 21 11:04:00 CST 2018, time=2018-10-21, status=1, ipAttribution=)]

2021-09-23 yjq08018275

请问一下，这个杂志投稿后需要每个作者确认吗？我投稿三天了还显示Submitted to Journal 是不是没有确认的原因啊

69 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1054059, encodeId=be481054059b8, content=请问一下，这个杂志投稿后需要每个作者确认吗？我投稿三天了还显示Submitted to Journal 是不是没有确认的原因啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Sep 23 09:21:08 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891913, encodeId=910a8919137f, content=三周以内投稿两篇letter，居然都接收了。letter的审稿还是比较快的，提交到系统后直接进入under review，中间时间变过几次，后面差不多一周时间就直接接到accept的通知了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Wed Oct 14 02:10:06 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926572, encodeId=b9fc9265e26a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3天秒拒，无理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb982473146, createdName=124403eem74暂无昵称, createdTime=Tue Feb 23 12:45:59 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908527, encodeId=027b90852e82, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿很快，没有实质yiji, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Wed Dec 16 13:05:08 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591503, encodeId=de6b59150325, content=请问with editor几天送审了后来？xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, beContent=xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587798, encodeId=7dca58e798b9, content=给各种战友友情提醒一下： 这个期刊不收动物模型的文章，谨慎选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:12:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583277, encodeId=017f5832e798, content=投稿后with editor第7天了，不知道有没有机会送外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a7e45998, createdName=xmcx783, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565021, encodeId=8a2b565021a4, content=IBD临床研究一篇，2018年5月8日投稿，7月18日一审结果建议大修，9月13日修回，10月23日二审结果建议1个月小修，10月24日修回，11月8日接收。12月30日Proof。等待在线中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aca20850, createdName=zhu19820122, createdTime=Mon Dec 31 23:18:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563647, encodeId=d29256364e61, content=请问一下，这个杂志接收基础文章吗？最近做了一个分子在肠炎中的作用，临床，细胞，动物都有。并纯化了该分子蛋白证明其有临床治疗价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Nov 26 00:00:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562218, encodeId=83da5622186e, content=投了个图片报道，审稿一个月了，今天变成了 Awaiting Final Decision。。。。就一个审稿人，战友们给评估下，希望多大？担忧中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Sun Oct 21 11:04:00 CST 2018, time=2018-10-21, status=1, ipAttribution=)]

2020-10-14 1484bf18m20暂无昵称

三周以内投稿两篇letter，居然都接收了。letter的审稿还是比较快的，提交到系统后直接进入under review，中间时间变过几次，后面差不多一周时间就直接接到accept的通知了

230 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1054059, encodeId=be481054059b8, content=请问一下，这个杂志投稿后需要每个作者确认吗？我投稿三天了还显示Submitted to Journal 是不是没有确认的原因啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Sep 23 09:21:08 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891913, encodeId=910a8919137f, content=三周以内投稿两篇letter，居然都接收了。letter的审稿还是比较快的，提交到系统后直接进入under review，中间时间变过几次，后面差不多一周时间就直接接到accept的通知了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Wed Oct 14 02:10:06 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926572, encodeId=b9fc9265e26a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3天秒拒，无理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb982473146, createdName=124403eem74暂无昵称, createdTime=Tue Feb 23 12:45:59 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908527, encodeId=027b90852e82, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿很快，没有实质yiji, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Wed Dec 16 13:05:08 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591503, encodeId=de6b59150325, content=请问with editor几天送审了后来？xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, beContent=xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587798, encodeId=7dca58e798b9, content=给各种战友友情提醒一下： 这个期刊不收动物模型的文章，谨慎选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:12:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583277, encodeId=017f5832e798, content=投稿后with editor第7天了，不知道有没有机会送外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a7e45998, createdName=xmcx783, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565021, encodeId=8a2b565021a4, content=IBD临床研究一篇，2018年5月8日投稿，7月18日一审结果建议大修，9月13日修回，10月23日二审结果建议1个月小修，10月24日修回，11月8日接收。12月30日Proof。等待在线中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aca20850, createdName=zhu19820122, createdTime=Mon Dec 31 23:18:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563647, encodeId=d29256364e61, content=请问一下，这个杂志接收基础文章吗？最近做了一个分子在肠炎中的作用，临床，细胞，动物都有。并纯化了该分子蛋白证明其有临床治疗价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Nov 26 00:00:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562218, encodeId=83da5622186e, content=投了个图片报道，审稿一个月了，今天变成了 Awaiting Final Decision。。。。就一个审稿人，战友们给评估下，希望多大？担忧中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Sun Oct 21 11:04:00 CST 2018, time=2018-10-21, status=1, ipAttribution=)]

2021-02-23 124403eem74暂无昵称

审稿速度:1.0 | 投稿命中率:25.0
经验分享：3天秒拒，无理由

124 0

[GetPortalCommentsPageByObjectIdResponse(id=1054059, encodeId=be481054059b8, content=请问一下，这个杂志投稿后需要每个作者确认吗？我投稿三天了还显示Submitted to Journal 是不是没有确认的原因啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Sep 23 09:21:08 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891913, encodeId=910a8919137f, content=三周以内投稿两篇letter，居然都接收了。letter的审稿还是比较快的，提交到系统后直接进入under review，中间时间变过几次，后面差不多一周时间就直接接到accept的通知了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Wed Oct 14 02:10:06 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926572, encodeId=b9fc9265e26a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3天秒拒，无理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb982473146, createdName=124403eem74暂无昵称, createdTime=Tue Feb 23 12:45:59 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908527, encodeId=027b90852e82, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿很快，没有实质yiji, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Wed Dec 16 13:05:08 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591503, encodeId=de6b59150325, content=请问with editor几天送审了后来？xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, beContent=xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587798, encodeId=7dca58e798b9, content=给各种战友友情提醒一下： 这个期刊不收动物模型的文章，谨慎选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:12:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583277, encodeId=017f5832e798, content=投稿后with editor第7天了，不知道有没有机会送外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a7e45998, createdName=xmcx783, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565021, encodeId=8a2b565021a4, content=IBD临床研究一篇，2018年5月8日投稿，7月18日一审结果建议大修，9月13日修回，10月23日二审结果建议1个月小修，10月24日修回，11月8日接收。12月30日Proof。等待在线中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aca20850, createdName=zhu19820122, createdTime=Mon Dec 31 23:18:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563647, encodeId=d29256364e61, content=请问一下，这个杂志接收基础文章吗？最近做了一个分子在肠炎中的作用，临床，细胞，动物都有。并纯化了该分子蛋白证明其有临床治疗价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Nov 26 00:00:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562218, encodeId=83da5622186e, content=投了个图片报道，审稿一个月了，今天变成了 Awaiting Final Decision。。。。就一个审稿人，战友们给评估下，希望多大？担忧中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Sun Oct 21 11:04:00 CST 2018, time=2018-10-21, status=1, ipAttribution=)]

2020-12-16 12107b02m29(暂无昵称)

审稿速度:1.0 | 投稿命中率:5.0
经验分享：拒稿很快，没有实质yiji

108 0

[GetPortalCommentsPageByObjectIdResponse(id=1054059, encodeId=be481054059b8, content=请问一下，这个杂志投稿后需要每个作者确认吗？我投稿三天了还显示Submitted to Journal 是不是没有确认的原因啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Sep 23 09:21:08 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891913, encodeId=910a8919137f, content=三周以内投稿两篇letter，居然都接收了。letter的审稿还是比较快的，提交到系统后直接进入under review，中间时间变过几次，后面差不多一周时间就直接接到accept的通知了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Wed Oct 14 02:10:06 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926572, encodeId=b9fc9265e26a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3天秒拒，无理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb982473146, createdName=124403eem74暂无昵称, createdTime=Tue Feb 23 12:45:59 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908527, encodeId=027b90852e82, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿很快，没有实质yiji, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Wed Dec 16 13:05:08 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591503, encodeId=de6b59150325, content=请问with editor几天送审了后来？xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, beContent=xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587798, encodeId=7dca58e798b9, content=给各种战友友情提醒一下： 这个期刊不收动物模型的文章，谨慎选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:12:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583277, encodeId=017f5832e798, content=投稿后with editor第7天了，不知道有没有机会送外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a7e45998, createdName=xmcx783, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565021, encodeId=8a2b565021a4, content=IBD临床研究一篇，2018年5月8日投稿，7月18日一审结果建议大修，9月13日修回，10月23日二审结果建议1个月小修，10月24日修回，11月8日接收。12月30日Proof。等待在线中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aca20850, createdName=zhu19820122, createdTime=Mon Dec 31 23:18:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563647, encodeId=d29256364e61, content=请问一下，这个杂志接收基础文章吗？最近做了一个分子在肠炎中的作用，临床，细胞，动物都有。并纯化了该分子蛋白证明其有临床治疗价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Nov 26 00:00:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562218, encodeId=83da5622186e, content=投了个图片报道，审稿一个月了，今天变成了 Awaiting Final Decision。。。。就一个审稿人，战友们给评估下，希望多大？担忧中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Sun Oct 21 11:04:00 CST 2018, time=2018-10-21, status=1, ipAttribution=)]

2020-05-22 1258faf6m29暂无昵称

请问with editor几天送审了后来？xmcx783 2020-01-14 00:00:00 发表:
投稿后with editor第7天了，不知道有没有机会送外审。

xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。

140 0

[GetPortalCommentsPageByObjectIdResponse(id=1054059, encodeId=be481054059b8, content=请问一下，这个杂志投稿后需要每个作者确认吗？我投稿三天了还显示Submitted to Journal 是不是没有确认的原因啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Sep 23 09:21:08 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891913, encodeId=910a8919137f, content=三周以内投稿两篇letter，居然都接收了。letter的审稿还是比较快的，提交到系统后直接进入under review，中间时间变过几次，后面差不多一周时间就直接接到accept的通知了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Wed Oct 14 02:10:06 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926572, encodeId=b9fc9265e26a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3天秒拒，无理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb982473146, createdName=124403eem74暂无昵称, createdTime=Tue Feb 23 12:45:59 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908527, encodeId=027b90852e82, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿很快，没有实质yiji, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Wed Dec 16 13:05:08 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591503, encodeId=de6b59150325, content=请问with editor几天送审了后来？xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, beContent=xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587798, encodeId=7dca58e798b9, content=给各种战友友情提醒一下： 这个期刊不收动物模型的文章，谨慎选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:12:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583277, encodeId=017f5832e798, content=投稿后with editor第7天了，不知道有没有机会送外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a7e45998, createdName=xmcx783, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565021, encodeId=8a2b565021a4, content=IBD临床研究一篇，2018年5月8日投稿，7月18日一审结果建议大修，9月13日修回，10月23日二审结果建议1个月小修，10月24日修回，11月8日接收。12月30日Proof。等待在线中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aca20850, createdName=zhu19820122, createdTime=Mon Dec 31 23:18:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563647, encodeId=d29256364e61, content=请问一下，这个杂志接收基础文章吗？最近做了一个分子在肠炎中的作用，临床，细胞，动物都有。并纯化了该分子蛋白证明其有临床治疗价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Nov 26 00:00:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562218, encodeId=83da5622186e, content=投了个图片报道，审稿一个月了，今天变成了 Awaiting Final Decision。。。。就一个审稿人，战友们给评估下，希望多大？担忧中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Sun Oct 21 11:04:00 CST 2018, time=2018-10-21, status=1, ipAttribution=)]

2020-03-31 壮壮一人暮

给各种战友友情提醒一下：
这个期刊不收动物模型的文章，谨慎选择。

165 0

[GetPortalCommentsPageByObjectIdResponse(id=1054059, encodeId=be481054059b8, content=请问一下，这个杂志投稿后需要每个作者确认吗？我投稿三天了还显示Submitted to Journal 是不是没有确认的原因啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Sep 23 09:21:08 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891913, encodeId=910a8919137f, content=三周以内投稿两篇letter，居然都接收了。letter的审稿还是比较快的，提交到系统后直接进入under review，中间时间变过几次，后面差不多一周时间就直接接到accept的通知了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Wed Oct 14 02:10:06 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926572, encodeId=b9fc9265e26a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3天秒拒，无理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb982473146, createdName=124403eem74暂无昵称, createdTime=Tue Feb 23 12:45:59 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908527, encodeId=027b90852e82, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿很快，没有实质yiji, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Wed Dec 16 13:05:08 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591503, encodeId=de6b59150325, content=请问with editor几天送审了后来？xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, beContent=xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587798, encodeId=7dca58e798b9, content=给各种战友友情提醒一下： 这个期刊不收动物模型的文章，谨慎选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:12:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583277, encodeId=017f5832e798, content=投稿后with editor第7天了，不知道有没有机会送外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a7e45998, createdName=xmcx783, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565021, encodeId=8a2b565021a4, content=IBD临床研究一篇，2018年5月8日投稿，7月18日一审结果建议大修，9月13日修回，10月23日二审结果建议1个月小修，10月24日修回，11月8日接收。12月30日Proof。等待在线中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aca20850, createdName=zhu19820122, createdTime=Mon Dec 31 23:18:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563647, encodeId=d29256364e61, content=请问一下，这个杂志接收基础文章吗？最近做了一个分子在肠炎中的作用，临床，细胞，动物都有。并纯化了该分子蛋白证明其有临床治疗价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Nov 26 00:00:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562218, encodeId=83da5622186e, content=投了个图片报道，审稿一个月了，今天变成了 Awaiting Final Decision。。。。就一个审稿人，战友们给评估下，希望多大？担忧中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Sun Oct 21 11:04:00 CST 2018, time=2018-10-21, status=1, ipAttribution=)]

2020-01-14 xmcx783

投稿后with editor第7天了，不知道有没有机会送外审。

187 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1054059, encodeId=be481054059b8, content=请问一下，这个杂志投稿后需要每个作者确认吗？我投稿三天了还显示Submitted to Journal 是不是没有确认的原因啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Sep 23 09:21:08 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891913, encodeId=910a8919137f, content=三周以内投稿两篇letter，居然都接收了。letter的审稿还是比较快的，提交到系统后直接进入under review，中间时间变过几次，后面差不多一周时间就直接接到accept的通知了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Wed Oct 14 02:10:06 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926572, encodeId=b9fc9265e26a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3天秒拒，无理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb982473146, createdName=124403eem74暂无昵称, createdTime=Tue Feb 23 12:45:59 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908527, encodeId=027b90852e82, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿很快，没有实质yiji, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Wed Dec 16 13:05:08 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591503, encodeId=de6b59150325, content=请问with editor几天送审了后来？xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, beContent=xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587798, encodeId=7dca58e798b9, content=给各种战友友情提醒一下： 这个期刊不收动物模型的文章，谨慎选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:12:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583277, encodeId=017f5832e798, content=投稿后with editor第7天了，不知道有没有机会送外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a7e45998, createdName=xmcx783, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565021, encodeId=8a2b565021a4, content=IBD临床研究一篇，2018年5月8日投稿，7月18日一审结果建议大修，9月13日修回，10月23日二审结果建议1个月小修，10月24日修回，11月8日接收。12月30日Proof。等待在线中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aca20850, createdName=zhu19820122, createdTime=Mon Dec 31 23:18:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563647, encodeId=d29256364e61, content=请问一下，这个杂志接收基础文章吗？最近做了一个分子在肠炎中的作用，临床，细胞，动物都有。并纯化了该分子蛋白证明其有临床治疗价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Nov 26 00:00:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562218, encodeId=83da5622186e, content=投了个图片报道，审稿一个月了，今天变成了 Awaiting Final Decision。。。。就一个审稿人，战友们给评估下，希望多大？担忧中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Sun Oct 21 11:04:00 CST 2018, time=2018-10-21, status=1, ipAttribution=)]

2018-12-31 zhu19820122

IBD临床研究一篇，2018年5月8日投稿，7月18日一审结果建议大修，9月13日修回，10月23日二审结果建议1个月小修，10月24日修回，11月8日接收。12月30日Proof。等待在线中。

253 0

[GetPortalCommentsPageByObjectIdResponse(id=1054059, encodeId=be481054059b8, content=请问一下，这个杂志投稿后需要每个作者确认吗？我投稿三天了还显示Submitted to Journal 是不是没有确认的原因啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Sep 23 09:21:08 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891913, encodeId=910a8919137f, content=三周以内投稿两篇letter，居然都接收了。letter的审稿还是比较快的，提交到系统后直接进入under review，中间时间变过几次，后面差不多一周时间就直接接到accept的通知了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Wed Oct 14 02:10:06 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926572, encodeId=b9fc9265e26a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3天秒拒，无理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb982473146, createdName=124403eem74暂无昵称, createdTime=Tue Feb 23 12:45:59 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908527, encodeId=027b90852e82, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿很快，没有实质yiji, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Wed Dec 16 13:05:08 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591503, encodeId=de6b59150325, content=请问with editor几天送审了后来？xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, beContent=xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587798, encodeId=7dca58e798b9, content=给各种战友友情提醒一下： 这个期刊不收动物模型的文章，谨慎选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:12:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583277, encodeId=017f5832e798, content=投稿后with editor第7天了，不知道有没有机会送外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a7e45998, createdName=xmcx783, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565021, encodeId=8a2b565021a4, content=IBD临床研究一篇，2018年5月8日投稿，7月18日一审结果建议大修，9月13日修回，10月23日二审结果建议1个月小修，10月24日修回，11月8日接收。12月30日Proof。等待在线中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aca20850, createdName=zhu19820122, createdTime=Mon Dec 31 23:18:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563647, encodeId=d29256364e61, content=请问一下，这个杂志接收基础文章吗？最近做了一个分子在肠炎中的作用，临床，细胞，动物都有。并纯化了该分子蛋白证明其有临床治疗价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Nov 26 00:00:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562218, encodeId=83da5622186e, content=投了个图片报道，审稿一个月了，今天变成了 Awaiting Final Decision。。。。就一个审稿人，战友们给评估下，希望多大？担忧中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Sun Oct 21 11:04:00 CST 2018, time=2018-10-21, status=1, ipAttribution=)]

2018-11-26 Godmin

请问一下，这个杂志接收基础文章吗？最近做了一个分子在肠炎中的作用，临床，细胞，动物都有。并纯化了该分子蛋白证明其有临床治疗价值

210 0

[GetPortalCommentsPageByObjectIdResponse(id=1054059, encodeId=be481054059b8, content=请问一下，这个杂志投稿后需要每个作者确认吗？我投稿三天了还显示Submitted to Journal 是不是没有确认的原因啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Sep 23 09:21:08 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891913, encodeId=910a8919137f, content=三周以内投稿两篇letter，居然都接收了。letter的审稿还是比较快的，提交到系统后直接进入under review，中间时间变过几次，后面差不多一周时间就直接接到accept的通知了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Wed Oct 14 02:10:06 CST 2020, time=2020-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926572, encodeId=b9fc9265e26a, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3天秒拒，无理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb982473146, createdName=124403eem74暂无昵称, createdTime=Tue Feb 23 12:45:59 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908527, encodeId=027b90852e82, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿很快，没有实质yiji, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Wed Dec 16 13:05:08 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591503, encodeId=de6b59150325, content=请问with editor几天送审了后来？xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, beContent=xmcx783 2020-01-14 00:00:00 发表: 投稿后with editor第7天了，不知道有没有机会送外审。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587798, encodeId=7dca58e798b9, content=给各种战友友情提醒一下： 这个期刊不收动物模型的文章，谨慎选择。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:12:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583277, encodeId=017f5832e798, content=投稿后with editor第7天了，不知道有没有机会送外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a7e45998, createdName=xmcx783, createdTime=Tue Jan 14 00:00:00 CST 2020, time=2020-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565021, encodeId=8a2b565021a4, content=IBD临床研究一篇，2018年5月8日投稿，7月18日一审结果建议大修，9月13日修回，10月23日二审结果建议1个月小修，10月24日修回，11月8日接收。12月30日Proof。等待在线中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aca20850, createdName=zhu19820122, createdTime=Mon Dec 31 23:18:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563647, encodeId=d29256364e61, content=请问一下，这个杂志接收基础文章吗？最近做了一个分子在肠炎中的作用，临床，细胞，动物都有。并纯化了该分子蛋白证明其有临床治疗价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Mon Nov 26 00:00:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562218, encodeId=83da5622186e, content=投了个图片报道，审稿一个月了，今天变成了 Awaiting Final Decision。。。。就一个审稿人，战友们给评估下，希望多大？担忧中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Sun Oct 21 11:04:00 CST 2018, time=2018-10-21, status=1, ipAttribution=)]

2018-10-21 赤脚草医

投了个图片报道，审稿一个月了，今天变成了 Awaiting Final Decision。。。。就一个审稿人，战友们给评估下，希望多大？担忧中

268 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务